Alligator Bioscience AB: Interim report January - June 2017
August 23, 2017 07:01 ET
|
Alligator Bioscience AB
Alligator Bioscience AB ((Nasdaq Stockholm; ATORX) Interim report January - June 2017 "We have advanced our project pipeline significantly during the second quarter. The immuno-oncology antibody...
Aptevo Therapeutics and Alligator Bioscience commence IND-enabling development activities for new bispecific immunotherapy candidate ALG.APV-527
August 17, 2017 07:01 ET
|
Alligator Bioscience AB
Aptevo Therapeutics and Alligator Bioscience commence IND-enabling development activities for new bispecific immunotherapy candidate ALG.APV-527 Novel Bispecific Antibody Targeting Biological...
Alligator Bioscience AB: Alligator expands immuno-oncology collaboration with Stanford University
August 07, 2017 07:00 ET
|
Alligator Bioscience AB
Press release, August 7, 2017 Alligator expands immuno-oncology collaboration with Stanford University Lund, Sweden - Alligator Bioscience AB (Nasdaq Stockholm; ATORX), a biotechnology...
Alligator Bioscience AB: Aptevo Therapeutics and Alligator Bioscience announce plans to co-develop novel bispecific antibody for tumor-directed immunotherapy
July 21, 2017 01:05 ET
|
Alligator Bioscience AB
Press release, July 21, 2017 Aptevo Therapeutics and Alligator Bioscience announce plans to co-develop novel bispecific antibody for tumor-directed immunotherapy Strategic partnership will...
Alligator Bioscience AB: Alligator Bioscience presents promising immuno-oncology data at US conference
May 04, 2017 14:23 ET
|
Alligator Bioscience AB
Press release, May 4, 2017 Alligator Bioscience presents promising immuno-oncology data at US conference- Strong new preclinical findings for ADC-1013 and ATOR-1015 Lund, Sweden - Alligator...
Alligator Bioscience AB: Interim report January-March 2017
May 02, 2017 10:07 ET
|
Alligator Bioscience AB
Press release, May 2, 2017 Alligator Bioscience AB Interim report January-March 2017 Lund, Sweden - Alligator Bioscience AB (Nasdaq Stockholm; ATORX) today announced its report for the first...